Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
20 authors at 4 institutions in 1 country.
Sangsin LeeLaboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0009-0003-3397-7301
Seung Geun SongDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-1605-2708
Gwanghun KimDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-8694-4365
Sehui KimDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-6640-3051
Hyun Jung YooLaboratory of Immunology and Vaccine Innovation, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Korea.ORCID 0000-0003-4074-6432
Jaemoon KohDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-2824-5080
Ye-Ji KimDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-7155-9635
Jingwen TianDepartment of Medical Science, Chungnam National University College of Medicine, Daejeon, Korea.ORCID 0000-0003-3500-4821
Eunji ChoDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-8486-3641
Youn Soo ChoiDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-6291-6178
Sunghoe ChangDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-3446-7288
Hyun Mu ShinDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-4521-8391
Kyeong Cheon JungDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-7741-7184
Ji Hoon KimDepartment of Pathology, Asan Medical Center (AMC), Ulsan University College of Medicine, Seoul, Korea.
Tae Min KimDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-6145-4426
Yoon Kyung JeonDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-8466-9681
Hye Young KimDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-5978-512X
Minho ShongGraduate School of Medical Science and Engineering, Korean Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.ORCID 0000-0002-0247-7115
Ji Hyung KimLaboratory of Immunology and Vaccine Innovation, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Korea.ORCID 0000-0001-6785-2345
Doo Hyun ChungLaboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-9948-8485
Seoul National University · KRKorea University · KRChungnam National University · KRKorea Advanced Institute of Science and Technology · KR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Recently identified human FOXP3
Indexed as
Matrix Attachment Region Binding ProteinsMitochondrial DiseasesNeoplasmsAnimalsCytokinesForkhead Transcription FactorsHumansKetoglutaric AcidsMiceT-Lymphocytes, RegulatoryCytokinesForkhead Transcription FactorsFOXP3 protein, humanKetoglutaric AcidsMatrix Attachment Region Binding ProteinsSATB1 protein, human
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
CRIF1 deficiency induces FOXP3 · full record | OpenQuestion